China says it began public use of covid-19 vaccine a month ago, bypassing clinical trials
Officials around the world have been debating how far they should suspend ordinary drug-development protocols to get covid-19 vaccines and treatments to market. Many governments declared early on that they would not cut corners in developing a vaccine, but they are proving amenable in practice to corner-cutting as the pandemic’s human and economic tolls mount.
The Beijing announcement followed a diplomatic controversy last week, when Papua New Guinea said it had turned back a group of Chinese miners who had received an experimental coronavirus vaccine.
There were signs of impatience in the White House as Beijing trumpeted its vaccine rollout over the weekend. President Trump tweeted Saturday alleging that either the Food and Drug Administration or the “deep state” was delaying progress for a U.S. coronavirus vaccine, without providing substantiating detail. On Sunday, Trump touted the FDA’s emergency authorization of convalescent plasma as a treatment for covid-19, the disease caused by the novel coronavirus.
The standard approval process for a new vaccine takes years and requires the observation of …continued .
[Source: Washington Post]